tiprankstipranks
10x Genomics Inc (TXG)
NASDAQ:TXG
Holding TXG?
Track your performance easily

10x Genomics (TXG) Financial Statements

958 Followers

10x Genomics Financial Overview

10x Genomics's market cap is currently ―. The company's EPS TTM is $-1.526; its P/E ratio is -10.41; 10x Genomics is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 151.65M$ 153.10M$ 141.01M$ 183.98M$ 153.64M
Gross Profit$ 106.39M$ 104.22M$ 92.91M$ 115.78M$ 95.53M
EBIT$ -34.44M$ -37.08M$ -57.80M$ -46.59M$ -91.74M
EBITDA$ -23.69M$ -26.18M$ -46.31M$ -34.88M$ -80.32M
Net Income Common Stockholders$ -35.75M$ -37.90M$ -59.95M$ -48.95M$ -92.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 398.16M$ 380.09M$ 371.81M$ 388.69M$ 356.91M
Total Assets$ 937.79M$ 929.67M$ 922.91M$ 965.14M$ 948.54M
Total Debt$ 85.88M$ 89.48M$ 92.18M$ 95.37M$ 98.47M
Net Debt$ -312.28M$ -290.61M$ -279.64M$ -293.32M$ -258.43M
Total Liabilities$ 214.99M$ 205.61M$ 204.08M$ 224.10M$ 203.32M
Stockholders Equity$ 722.80M$ 724.06M$ 718.83M$ 741.04M$ 745.22M
Cash Flow-
Free Cash Flow$ 17.75M$ 3.62M$ -18.64M$ 22.31M$ -40.74M
Operating Cash Flow$ 21.64M$ 7.50M$ -15.72M$ 25.76M$ -25.30M
Investing Cash Flow$ -3.62M$ 11.95M$ 10.63M$ 13.10M$ 4.90M
Financing Cash Flow$ 156.00K$ 4.60M$ 1.64M$ 5.61M$ 4.37M
Currency in USD

10x Genomics Earnings and Revenue History

10x Genomics Debt to Assets

10x Genomics Cash Flow

10x Genomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis